Elevated hemoglobin A1c is associated with readmission but not complications

Area of Science:

• Cardiology
• Endocrinology
• Surgical Outcomes

Background:

• Elevated hemoglobin A1c (HbA1c) is linked to adverse short-term outcomes post-cardiac surgery.
• The impact of preoperative HbA1c on hospital readmission remains understudied.
• This research investigates the independent association between HbA1c levels and readmission rates.

Purpose of the Study:

• To determine if preoperative hemoglobin A1c levels independently predict readmission after cardiac surgery.
• To assess the relationship between preoperative HbA1c levels and the incidence of postoperative complications.
• To evaluate the effect of preoperative HbA1c levels on mortality following cardiac surgery.

Main Methods:

• A cohort of 300 patients undergoing coronary artery bypass surgery was analyzed.
• Patients were stratified into three groups based on preoperative hemoglobin A1c levels (<6.0%, 6.0%-6.9%, and ≥7.0%).
• Outcomes were adjusted for demographic factors, comorbidities, and surgical variables.

Main Results:

• Patients with elevated HbA1c levels (≥6.0%) showed a doubled risk of readmission compared to those with normal levels (adjusted ORs ~2.09, p=0.036).
• No significant difference in postoperative complications was observed across HbA1c groups (p=0.837).
• Mortality rates were equivalent among all HbA1c groups.

Conclusions:

• Preoperative elevated hemoglobin A1c levels are an independent predictor of increased readmission risk after cardiac surgery.
• Elevated HbA1c levels were not associated with a higher risk of postoperative complications or mortality.
• Glycemic control, indicated by HbA1c, is crucial for optimizing post-cardiac surgery recovery and reducing readmissions.